# Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/octreotide-acetate-long-acting-formulation-versus-open-label-subcutaneous/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Joseph Rubin,Jaffer A. Ajani,William J. Schirmer,Alan P. Venook,Ronald M. Bukowski,Rodney F. Pommier,Leonard B. Saltz,Paresh Dandona,Lowell Anthony |
| Citations | 389 |
| DOI | 10.1200/jco.1999.17.2.600 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1898402948 |
| PMID | 10080605 |
| Type | article |
| Year | 1999 |

## Paper authors

- [Rodney F. Pommier](https://scholariq.org/researchers/rodney-f-pommier/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)
- [Pancreatitis Pathology and Treatment](https://scholariq.org/topics/pancreatitis-pathology-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.